SRY-positive 45,X/46,XY karyotype in a phenotypically Turner-like Chinese adolescent female with ovarian dysgerminoma and gonadoblastoma
Author:
Zhou Jiahong1, Zhan Ping2, Cheng Yang1, Luo Qing1, Chai Li3, Yuan Lan1, Zhu Xidan1, Liu Jinbo1
Affiliation:
1. Department of Laboratory Medicine , The Affiliated Hospital of Southwest Medical University, Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou , Sichuan , China 2. Department of Gynecology , The Affiliated Hospital of Southwest Medical University , Luzhou China 3. Department of Pathology , The Affiliated Hospital of Southwest Medical University , Luzhou China
Abstract
Abstract
Objectives
45,X/46,XY mosaicism is a rare condition with clinical and genetic heterogeneity and have a greatly increased risk of developing germ cell tumors. We describe a rare 45,X/46,XY Chinese girl with malignant tumors, especially focusing on the molecular genetics of gonadal tumor.
Case presentation
We report a phenotypically Turner-like Chinese adolescent girl who presented primary amenorrhea and a pelvic mass as the chief complaint, which finally demonstrated dysgerminoma replacing the left gonad and gonadoblastoma arising from right gonad respectively. Her chromosome karyotype was 45,X(4)/46,XY(46); Y-chromosome microdeletions in AZFb regions were found on gonadal DNA rather than peripheral blood lymphocyte (PBL) DNA, while no variants were found in the promoter and coding region of SRY gene in both PBL and gonadal tissues. She underwent bilateral gonadectomy; no recurrence or serious complications were identified after 3 years of follow-up.
Conclusions
This case emphasizes the probable correlation between Y chromosome microdeletions in gonadal tissue and the severity of the phenotype in patients with 45,X/46,XY mosaicism and highlights the importance of clinical genetic testing at the chromosomal and molecular level.
Funder
Sichuan Science and Technology Program
Publisher
Walter de Gruyter GmbH
Reference17 articles.
1. Lee, PA, Nordenstrom, A, Houk, CP, Ahmed, SF, Auchus, R, Baratz, A, et al.. Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr 2016;85:158–80. https://doi.org/10.1159/000442975. 2. Rosa, RF, D’Ecclesiis, WF, Dibbi, RP, Rosa, RC, Trevisan, P, Graziadio, C, et al.. 45,X/46,XY mosaicism: report on 14 patients from a Brazilian hospital. A retrospective study. Sao Paulo Med J 2014;132:332–8. https://doi.org/10.1590/1516-3180.2014.1326729. 3. Cools, M, Pleskacova, J, Stoop, H, Hoebeke, P, Van Laecke, E, Drop, SL, et al.. Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J Clin Endocrinol Metab 2011;96:E1171–80. https://doi.org/10.1210/jc.2011-0232. 4. Matsumoto, F, Matsuyama, S, Matsui, F, Yazawa, K, Matsuoka, K. Variation of gonadal dysgenesis and tumor risk in patients with 45,X/46,XY mosaicism. Urology 2020;137:157–60. https://doi.org/10.1016/j.urology.2019.12.014. 5. Karila, D, Donadille, B, Leger, J, Bouvattier, C, Bachelot, A, Kerlan, V, et al.. Prevalence and characteristics of gonadoblastoma in a retrospective multi-center study with follow-up investigations of 70 patients with Turner syndrome and a 45,X/46,XY karyotype. Eur J Endocrinol 2022;187:873–81. https://doi.org/10.1530/eje-22-0593.
|
|